utd_medknow
Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :543
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Breast Cancer Demographics, Types and Management Pathways: Can Western Algorithms be Optimally used in Eastern Countries?
S. Chakraborty,T. Wadasadawala,R. Ahmed,C. Coles,S. Chatterjee
Clinical Oncology.2019;31(8)502
[DOI]
2Alarming Burden of Triple-Negative Breast Cancer in India
Krishan K. Thakur,Devivasha Bordoloi,Ajaikumar B. Kunnumakkara
Clinical Breast Cancer.2018;18(3)e393
[DOI]
3Breast carcinoma histopathological correlation with molecular classification: A comparative study
Savita Soni,Neha Sethi,Aradhana Gupta,Ankita Singh Srivastava
Indian Journal of Pathology and Oncology.2020;7(4)613
[DOI]
4Triple-Negative Breast Cancer among Ghanaian Women Seen at Korle-Bu Teaching Hospital
E. M. Der,R. K. Gyasi,Y. Tettey,T. M. Bayor,L. Newman
African Journal of Pathology and Microbiology.2015;4(4)1
[DOI]
5Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis
Gurprataap S. Sandhu,Sebhat Erqou,Heidi Patterson,Aju Mathew
Journal of Global Oncology.2016;2(6)412
[DOI]
6Sentinel Lymph Node Biopsy in Early Breast Cancer Using Methylene Blue Dye Alone: a Safe, Simple, and Cost-Effective Procedure in Resource-Constrained Settings
Sreekar Devarakonda,Shawn Sam Thomas,Supriya Sen,Varghese Thomas,Reka Karuppusami,Anish Jacob Cherian,Pooja Ramakant,Deepak Thomas Abraham,Paul Mazhuvanchary Jacob
Indian Journal of Surgical Oncology.2021;12(1)210
[DOI]
7Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population
Tabassum Wadasadawala,Shirley Lewis,Vani Parmar,Ashwini Budrukkar,Sudeep Gupta,Nita Nair,Tanuja Shet,Rajendra Badwe,Rajiv Sarin
Clinical Breast Cancer.2018;18(4)e727
[DOI]
8The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research
Priya Ranganathan,Girish Chinnaswamy,Manju Sengar,Durga Gadgil,Shivakumar Thiagarajan,Balram Bhargava,Christopher M Booth,Marc Buyse,Sanjiv Chopra,Chris Frampton,Satish Gopal,Nick Grant,Mark Krailo,Ruth Langley,Prashant Mathur,Xavier Paoletti,Mahesh Parmar,Arnie Purushotham,Douglas Pyle,Preetha Rajaraman,Martin R Stockler,Richard Sullivan,Soumya Swaminathan,Ian Tannock,Edward Trimble,Rajendra A Badwe,C S Pramesh
The Lancet Oncology.2021;22(8)e369
[DOI]
9Prevalence of Molecular Subtypes of Breast Cancer in India: a Systematic Review and Meta-analysis
Pavan Kumar Jonnada,Cherukuru Sushma,Madhuri Karyampudi,Anvesh Dharanikota
Indian Journal of Surgical Oncology.2021;12(S1)152
[DOI]
10Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India
Nidhi Gupta,Rohan Kumar Verma,Sudeep Gupta,Shankar Prinja
JCO Global Oncology.2020;12(6)205
[DOI]
11Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients
Mukund Sable,Trupti D. Pai,Tanuja Shet,Asawari Patil,Sandeep Dhanavade,Sangeeta B. Desai
International Journal of Surgical Pathology.2017;25(3)230
[DOI]
12Epidemiology of breast cancer in Indian women
Shreshtha Malvia,Sarangadhara Appalaraju Bagadi,Uma S. Dubey,Sunita Saxena
Asia-Pacific Journal of Clinical Oncology.2017;13(4)289
[DOI]
13Differences in breast cancer hormone receptor status in ethnic groups: A London population
Ruth H. Jack,Elizabeth A. Davies,Christine Renshaw,Andrew Tutt,Melanie J. Grocock,Victoria H. Coupland,Henrik Møller
European Journal of Cancer.2013;49(3)696
[DOI]
14OESTROGEN, PROGESTERONE & HER2/NEU RECEPTOR STATUS IN PATIENTS WITH BREAST CARCINOMA WITH SPECIAL REFERENCE TO TRIPLE NEGATIVE STATUS IN A TERTIARY CARE HOSPITAL IN SOUTHERN ODISHA
Sushanta Kumar Das,Rakesh Kumar Nayak,Niranjan Sahoo,Sanjeeb Kumar Pradhan,Saket Saurabh,Pranab Kumar Prusty,Ashis Patra,Manjulkanta Padhan
Journal of Evidence Based Medicine and Healthcare.2019;6(12)959
[DOI]
15Challenges in the management of breast cancer in low- and middle-income countries
Cheng-Har Yip,Nur Aishah Taib
Future Oncology.2012;8(12)1575
[DOI]
16Clinical Trial Ethics: One Standard Does Not Fit All
Sudeep Gupta,Seema Gulia,Nishita Shetty
Journal of Clinical Oncology.2015;33(12)1413
[DOI]
17Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?
Gertruud Haitsma,Himanshu Patel,Parthasarathi Gurumurthy,Maarten J. Postma
Expert Review of Pharmacoeconomics & Outcomes Research.2018;18(3)289
[DOI]
18Clinicopathological Profile of Breast Cancer Patients at a Tertiary Care Hospital in Marathwada Region of Westen India
Unmesh Vidyadhar Takalkar,Shilpa Balaji Asegaonkar,Umesh Kulkarni,Pushpa R Kodlikeri,Ujwala Kulkarni,Mamta Saraf,Suresh Advani
Asian Pacific Journal of Cancer Prevention.2016;17(4)2195
[DOI]
19Challenges and opportunities in the design and implementation of breast cancer clinical trials in developing countries
Sudeep Gupta,Shona Nag,Shaheenah Dawood
Clinical Investigation.2012;2(6)579
[DOI]
20Current Treatment Options for Human Epidermal Growth Factor Receptor 2-Directed Therapy in Metastatic Breast Cancer: An Indian Perspective
Gupta Sudeep,Chatterjee Sanjoy,Nigade Jagdish,Aggarwal Shyam,Singhal Manish,SS Alurkar,Kukreja Anil,BK Smruti,Nag Shona,Agarwal Amit,Agarwal Vijay,R Chacko,Desai Chirag,Goswami Chanchal,Keechilat Pavithran,Patil Poonam,Prasad Krishna,Rajendranath Rejiv,RR Rao,TP Sahoo,Singh Ashish,Singh Randeep,Srinivasan Sankar,Warrier Arun,Swarup Binay,Bhattacharya Priyanka,SH Advani
Indian Journal of Medical and Paediatric Oncology.2018;39(03)368
[DOI]
21Adjuvant Short-Course Trastuzumab in Breast Cancer
Taha Sethjiwala,Manikandan Dhanushkodi,Venkatraman Radhakrishnan,Jayachandran Perumal Kalaiarasi,Nikita Mehra,Archit Joshi,Arun Kumar Rajan,Gangothri Selvarajan,Balasubramanian Ananthi,Priya Iyer,Geetha Senguttuvan,Bharathi Srilatha,Rama Ranganathan,Shirley Sundersingh,Arvind Krishnamurthy,Sridevi Velusamy,Hemanth Raj,Selvaluxmy Ganesarajah,Tenali Gnana Sagar,Trivadi S. Ganesan
Indian Journal of Gynecologic Oncology.2019;17(3)368
[DOI]
22Breast cancer treatment: A phased approach to implementation
Miriam Mutebi,Benjamin O. Anderson,Catherine Duggan,Clement Adebamowo,Gaurav Agarwal,Zipporah Ali,Peter Bird,Jean-Marc Bourque,Rebecca DeBoer,Luiz Henrique Gebrim,Riccardo Masetti,Shahla Masood,Manoj Menon,Gertrude Nakigudde,Anne Ng’ang’a,Nixon Niyonzima,Anne F. Rositch,Karla Unger-Saldaña,Cynthia Villarreal-Garza,Allison Dvaladze,Nagi S. El Saghir,Julie R. Gralow,Alexandru Eniu
Cancer.2020;126(S10)2365
[DOI]
23A Study of Hormone Receptor Status in Breast Carcinoma and use of HER2-Targeted Therapy in a Tertiary Care Center of India
Sandeep Bhaskar,Kartick Rastogi,Shivani Gupta,Arpita Jindal,Aseem Rai Bhatnagar,Sandeep Jain
Indian Journal of Medical and Paediatric Oncology.2019;40(S 01)S54
[DOI]
24UTILITY OF PANEL OF IMMUNO HISTOCHEMICAL MARKERS IN CARCINOMA BREAST-OUR EXPERIENCE IN A TERTIARY CARE HOSPITAL
Teleflo Boopathy,Vincy. T.M,Gowri Prakasam
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2021;40(S 01)35
[DOI]
25Breast Cancer Tumor Biology Characteristics and Its Correlation in a Tertiary Care Center
Jyoti Sharma,Tapan Kapoor,Guman Singh,Anushree Loyal,Dharam Pal Singh
Journal of Mahatma Gandhi University of Medical Sciences and Technology.2021;6(2)53
[DOI]
26The Relevance of Established Risk Factors in Context to Indian Breast Cancer Patients
Richa Chauhan
Women's Health.2016;3(2)53
[DOI]
27A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery
Dinesh Chandra Doval,Selvi Radhakrishna,Rupal Tripathi,Renu Iyer Kashinath,Vineet Talwar,Ullas Batra,Naga Amulya Mullapudi,Kapil Kumar,Ajay Kumar Dewan,Harit Chaturvedi,Juhi Tayal,Anurag Mehta,Sudeep Gupta,Ramesh B. V. Nimmagadda
Scientific Reports.2020;10(1)53
[DOI]
28A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery
Manvi Singh,Sradhanjali Mohapatra,Sradhanjali Sanskriti,Navneet Kaur,Abeeda Mushtaq,Sheikh Zahid,Arshad A. Pandith,Sheikh Mansoor,Zeenat Iqbal
Scientific Reports.2021;10(1)223
[DOI]
29Clinicopathological Characteristics and Prognosis of Breast Cancer in Young Women – A Single Center Study in a Developing Country
Xiaoliang Sun,Jun Liu,Haoyang Ji,Meng Yang,Yao Lu
Cancer Management and Research.2021;Volume 13(1)1601
[DOI]
30Outcomes of Breast Cancer Management from an Urban Specialist Breast Center in South India
Naga Amulya Mullapudi,Kabeer Katherine Kirti,Naveen Padmanaban,Ramesh Nimmagadda,Selvi Radhakrishna
Indian Journal of Medical and Paediatric Oncology.2019;40(S 01)S102
[DOI]
31Clinicopathological Profile of Breast Cancer Patients at a Tertiary Care Hospital in Kashmir Valley
Mujahid Ahmad Mir,Farzana Manzoor,Balvinder Singh,Wasim Raja,Shaukat Jeelani,Waheed Ahmad Zargar,Faraidon Faiq Ahmad,Aung Zar Ko,Imteyaz Ahmad Sofi
Surgical Science.2017;08(03)162
[DOI]
32Differences in Incidence, Mortality and Survival of Breast Cancer by Regions and Countries in Asia and Contributing Factors
Yeonju Kim,Keun-Young Yoo,Marc T Goodman
Asian Pacific Journal of Cancer Prevention.2015;16(7)2857
[DOI]
33The Impact of Stage and Molecular Subtypes on Survival Outcomes in Young Women with Breast Cancer
Nisha Hariharan,T. Subramanyeshwar Rao,Chandra K. Naidu,K.V.V.N. Raju,Senthil Rajappa,Santa Ayyagari,M.V.T. Krishnamohan,Sudha Murthy,Aparna Suryadevara,Naren Boleneni
Journal of Adolescent and Young Adult Oncology.2019;8(5)628
[DOI]
34Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer
Apurv Kulkarni,Devaki A. Kelkar,Nidhi Parikh,Lingadahalli S. Shashidhara,Chaitanyanand B. Koppiker,Madhura Kulkarni
JCO Global Oncology.2020;8(6)1052
[DOI]
35Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience
Edmund M. Der,Richard K. Gyasi,Yao Tettey,Lawrence Edusei,Marcel T. Bayor,Evelyn Jiagge,Mawuli Gyakobo,Sofia D. Merajver,Lisa A. Newman
The Breast Journal.2015;21(6)627
[DOI]
36Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance
Vijay M. Patil,Vanita Noronha,Amit Joshi,Vamshi Muddu,Sachin Dhumal,Atanu Bhattacharjee,Kumar Prabhash
Journal of Global Oncology.2015;1(2)65
[DOI]
37Drug repurposing in oncology—patient and health systems opportunities
Francesco Bertolini,Vikas P. Sukhatme,Gauthier Bouche
Nature Reviews Clinical Oncology.2015;12(12)732
[DOI]
38Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease
Jyothi S Prabhu,Aruna Korlimarla,C E Anupama,Annie Alexander,Rohini Raghavan,Roma Kaul,Krisha Desai,Savitha Rajarajan,Suraj Manjunath,Marjorrie Correa,R Raman,Anjali Kalamdani,MSN Prasad,Shekar Patil,K S Gopinath,B S Srinath,T.S. Sridhar
Translational Oncology.2017;10(4)699
[DOI]
39Current Status of Breast Cancer Management in India
Ajeet Pratap Maurya,Swagata Brahmachari
Indian Journal of Surgery.2020;10(4)699
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow